Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

PRAN 1.15 -0.01 (-0.86%)
price chart
Prana Biotechnology Stock Surges On Approval
Prana Biotechnology Limited (ADR) (PRAN) is up over 30% during trading today on the back of orphan drug designation for its drug PBT2.
Prana Biotechnology Limited leaps on potential breakthrough: Should you buy?  Motley Fool Australia
Prana Biotechnology's PBT2 receives FDA Orphan Drug designation  Proactive Investors Australia
Related articles »  
Should You Invest In Prana Biotechnology Limited (PRAN), IsoRay, Inc.(ISR) and ...
Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) lost $1.09 to finish the day at a closing price of $1.09. The 33.54% decline in value came on a day when the stock traded for as little as $1.07, a new 52 week low for Melbourne-based biotechnology ...
Prana Biotechnology Limited (ADR) (PRAN) news: Prana: Right Drug, Wrong Dose
Prana Biotechnology Limited (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer's disease within the coming month.
Short Interest in Prana Biotechnology Limited Declines By 40.3% (PRAN)
Receive News & Ratings for Prana Biotechnology Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology Limited and related companies with's FREE ...
BEST STOCKS TODAY: AVEO Pharmaceuticals, Inc., Prana Biotechnology Limited ADR ... provides it's members with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, and hidden stocks traded on the NASDAQ, NYSE, AMEX, and OTC Markets with the potential of fast gains.
Prana Biotechnology Limited responds to ASX speeding ticket: What you need ...  Motley Fool Australia
Why Prana Biotech's & Momenta Pharma's Stock Prices Fell Yesterday
Momenta Pharmaceutical (MNTA) was down 16.85% at the closing bell yesterday as Teva Pharmaceutical Industries Ltd. (ADR) (TEVA) got the green light from the Supreme Court, signaling that the court will consider its appeal for extension of the patent on ...
Prana Biotechnology Limited shares crash on trial results  The Motley Fool
Prana Biotech Plunges 76%; Drug Fails in Alzheimer Study  Bloomberg
Related articles »  
Why Prana Biotechnology Limited soared 33% today
Biotech company Prana Biotechnology Limited (ASX: PBT) saw its shares soar 33% to 22 cents in trading today, following similar gains (21%) in its NASDAQ-listed shares overnight.
Related articles »  
Prana Biotechnology Limited (ADR) (PRAN) news: Alzheimer's Dementia: Eli Lilly ...
In this article I will be analyzing the differences between Eli Lilly's (NYSE:LLY) Solanezumab and Prana Biotechnology's (NASDAQ:PRAN) PBT2 -- the new leading candidates in the treatment of Alzheimer's dementia and the implications for their ...
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotechnology - A Gamble ...
One company in particular, Prana Biotechnology (NASDAQ:PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.
Morning Buzz: ITT Educational Services Inc. (NYSE:ESI), Ignyta Inc(NASDAQ:RXDX ...
... and penny stocks, issues news alert on Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Ignyta Inc(NASDAQ:RXDX), ITT Educational Services Inc. (NYSE:ESI).
Prana Biotechnology Limited soars on positive news: Is it a spec buy?  Motley Fool Australia
Morning Buzz: Prana Biotechnology (PRAN), Heron Therapeutics (HRTX ...  CNA Finance (press release)